Adeno-associated virus: from defective virus to effective vector
- PMID: 15877812
- PMCID: PMC1131931
- DOI: 10.1186/1743-422X-2-43
Adeno-associated virus: from defective virus to effective vector
Abstract
The initial discovery of adeno-associated virus (AAV) mixed with adenovirus particles was not a fortuitous one but rather an expression of AAV biology. Indeed, as it came to be known, in addition to the unavoidable host cell, AAV typically needs a so-called helper virus such as adenovirus to replicate. Since the AAV life cycle revolves around another unrelated virus it was dubbed a satellite virus. However, the structural simplicity plus the defective and non-pathogenic character of this satellite virus caused recombinant forms to acquire centre-stage prominence in the current constellation of vectors for human gene therapy. In the present review, issues related to the development of recombinant AAV (rAAV) vectors, from the general principle to production methods, tropism modifications and other emerging technologies are discussed. In addition, the accumulating knowledge regarding the mechanisms of rAAV genome transduction and persistence is reviewed. The topics on rAAV vectorology are supplemented with information on the parental virus biology with an emphasis on aspects that directly impact on vector design and performance such as genome replication, genetic structure, and host cell entry.
Figures






Similar articles
-
Adeno-associated virus vectorology, manufacturing, and clinical applications.Methods Enzymol. 2012;507:229-54. doi: 10.1016/B978-0-12-386509-0.00012-0. Methods Enzymol. 2012. PMID: 22365777 Review.
-
High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.Gene Ther. 1999 Jun;6(6):986-93. doi: 10.1038/sj.gt.3300937. Gene Ther. 1999. PMID: 10455400
-
Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production.Biochem Biophys Res Commun. 2001 Oct 19;288(1):62-8. doi: 10.1006/bbrc.2001.5730. Biochem Biophys Res Commun. 2001. PMID: 11594752
-
Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.Gene Ther. 1999 Feb;6(2):293-9. doi: 10.1038/sj.gt.3300807. Gene Ther. 1999. PMID: 10435114
-
[Recombinant adeno-associated virus vector related impurities].Sheng Wu Gong Cheng Xue Bao. 2011 May;27(5):717-23. Sheng Wu Gong Cheng Xue Bao. 2011. PMID: 21845838 Review. Chinese.
Cited by
-
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG.PLoS One. 2016 Jun 22;11(6):e0158009. doi: 10.1371/journal.pone.0158009. eCollection 2016. PLoS One. 2016. PMID: 27332822 Free PMC article.
-
Gene delivery to neurons in the auditory brainstem of barn owls using standard recombinant adeno-associated virus vectors.Curr Res Neurobiol. 2020 Aug 6;1:100001. doi: 10.1016/j.crneur.2020.100001. eCollection 2020 Dec. Curr Res Neurobiol. 2020. PMID: 36249276 Free PMC article.
-
Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice.Hum Gene Ther Methods. 2013 Aug;24(4):205-13. doi: 10.1089/hgtb.2013.076. Epub 2013 Aug 3. Hum Gene Ther Methods. 2013. PMID: 23808551 Free PMC article.
-
Viral vectors and delivery strategies for CNS gene therapy.Ther Deliv. 2010 Oct;1(4):517-34. doi: 10.4155/tde.10.50. Ther Deliv. 2010. PMID: 22833965 Free PMC article. Review.
-
The Development of Methods for the Production of New Molecular Vaccines and Appropriate RNA Fragments to Counteract Unwanted Genes: A Pilot Study.Vaccines (Basel). 2023 Jul 11;11(7):1226. doi: 10.3390/vaccines11071226. Vaccines (Basel). 2023. PMID: 37515042 Free PMC article.
References
-
- Atchison RW, Castro BC, Hammon WM. Adenovirus-associated defective virus particles. Science. 1965;149:754–756. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources